![]() Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. | ![]() Societal CDMO Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. | ||
Founding Date | Founding Date 1996 | Founding Date 2006 | Founding Date 2006 |
Type | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Saint-Quentin-Fallavier, FR HQ | Locations Emeryville, US HQ Maidenhead, GB | Locations Gainesville, US HQ Gainesville, US San Diego, US |
Employees | Employees 2453% increase | Employees 743% increase | Employees 21316% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) £95.9m (FY, 2015) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) $94.6m (FY, 2023) |
Cost of goods | Cost of goods £43.1m (FY, 2015) | Cost of goods $4.8m (FY, 2021) | Cost of goods $76.5m (FY, 2023) |
Net income | Net income N/A | Net income ($227.4m) (FY, 2021) | Net income ($13.3m) (FY, 2023) |

Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View company
Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain.
View company